Data from 2 patients who received a potential functional cure for diabetes and more breaking news on the VX-880 trial progress (first stem cell-derived beta cell therapy for type 1 diabetes).

Watch next:
How to lower blood sugar fast https://youtu.be/0uv9Ol0aa18
Top 5 low carb meals that don’t spike blood glucose https://youtu.be/dbxnKifOSmc

Subscribe to my channel by clicking this link ?sub_confirmation=1
Join my Patreon community for bonus content and direct message option (I respond to all messages from patrons) https://www.patreon.com/typeonetalks
Follow me on Instagram https://www.instagram.com/typeonetalks
Book a diabetes coaching session with me https://calendly.com/typeonetalks

0:00 Data from the VX-880 trial – participant 1
2:29 What is the VX-880 stem cell derived beta cell therapy?
3:12 Data from the VX-880 trial – participant 2
4:01 Other important remarks and my thoughts
5:14 When will cure for type 1 diabetes be available

I regularly release videos covering diabetes topics. Let me know if you have any questions or topics you would like me to cover. I really appreciate your input!

Disclaimer: I am not a medical professional and my videos are not medical advice. What works for me might not work for others. The information discussed in this video is based on the below listed sources.
Please consult your medical professional regarding your diabetes treatment. I just share my views and my experience.

Disclosure: Links in the video description might include affiliate links (I will receive a small provision if you use these links for your purchase).

Used sources/Credits:
Andrew Briskin’s article https://diatribe.org/vertex-releases-new-data-potential-cure-for-type-1-diabetes
More on VX-880 https://diatribe.org/type-1-cures-sneak-peek-lab
CNBC documentary about VX-880 featuring Brian https://www.youtube.com/watch?v=E5bacxqobwY

#typeonetalks
Video Rating: / 5

Type 1 Diabetes is an autoimmune disease that leads to a loss of beta cells in the pancreas. These beta cells are part of a cellular complex that produce insulin, an essential hormone that regulates our blood sugar, keeping it within a narrow range, and thus allowing normal bodily functions to occur. To survive, patients must monitor and control their diet, track physical activity, carefully regularly measure their blood sugar levels, and inject the appropriate amount of insulin. But Paul Laikind and his team at ViaCyte are working on a functional cure that involves the use of stem cells which become pancreatic cells that can mature and produce insulin in a normal manner. Paul K. Laikind, Ph.D. has over 30 years of leadership experience in the biotechnology and life sciences industry in San Diego. He currently serves as President, CEO and a member of the Board of ViaCyte, Inc. a leading company in the emerging field of regenerative medicine. Prior to joining ViaCyte, Dr. Laikind served as Chief Business Officer and Senior Vice President of Business Development at the Sanford-Burnham Medical Research Institute. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
Video Rating: / 5

Share this page: